🇺🇸 FDA
Patent

US 10293022

Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10293022 (Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction) held by THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYTEM expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYTEM
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00, A61K38/08